Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Azelaic acid in a special gel is more effective against skin fungi than regular azelaic acid.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Ion sequential therapy improves heart function after a heart attack.

Ozenoxacin reduces sebum production, helping manage acne.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Co-trimoxazole may help treat autoimmune diseases.